Chandrashekhar Dasari

4PUBLICATIONS
41CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 24, 2025
Ex Vivo Expanded Regulatory T Cells Inhibit AAA Progression by Limiting CD4+ and CD8+ T Cell Accumulation in Aortic Tissue.

Chandrashekhar Dasari, Jose Luis Lopez, Masood Shawyan Jan

|Feb 13, 2025
Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy.

Anil P Bidkar, Robin Peter, Anju Wadhwa

|Sep 27, 2024
PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer.

Niranjan Meher, Anil P Bidkar, Anju Wadhwa

|Mar 14, 2023
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy.

Anil P Bidkar, Sinan Wang, Kondapa Naidu Bobba

Pageof 1